United Therapeutics Corporation (UTHR) - News Archive

As the vibrant city of Amsterdam prepares to unfold its annual European Respiratory Society (ERS) Congress from September 27 to October 1, 2025, the spotlight will illuminate United Therapeutics Corporation (Nasdaq: UTH...

In a significant development for the treatment of idiopathic pulmonary fibrosis (IPF), United Therapeutics Corporation, a leading public benefit corporation, has announced the full enrollment of the TETON 1 study. This...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, recently announced the completion of patient enrollment for the TETON 2 study. This signifi...

United Therapeutics Achieves Historic Milestone with First Successful Xenothymokidney TransplantOn April 12, 2024, United Therapeutics Corporation, a public benefit corporation, made history by successfully completing t...